SABBY MANAGEMENT, LLC Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
48
Insider Buys Sum
$1.49M
Insider Sells Quantity
2
Insider Sells Sum
$68,277.66

Insider Activity of SABBY MANAGEMENT, LLC

Biography of SABBY MANAGEMENT, LLC

No biography is available at this moment.

2014-04-15PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
17,100
0.3007%
$5.00$85,500+9.59%
2014-04-14PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
3,000
0.0539%
$5.21$15,630+7.49%
2014-04-11PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
100
0.0017%
$5.15$515+3.7%
2014-04-10PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
1,400
0.0252%
$5.25$7,350+6.67%
2014-04-09PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
1,075
0.0194%
$5.51$5,923+1.82%
2014-04-08PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
35,500
0.6218%
$5.36$190,280+1.82%
2014-04-07PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
20,654
0.3716%
$5.71$117,840-1.75%
2014-04-04PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
12,250
0.216%
$6.07$74,400-9.52%
2014-04-02PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
2,500
0.0441%
$6.15$15,375-10.45%
2014-04-01PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
15,371
0.2742%
$6.10$93,806-8.46%
2014-03-31PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
7,936
0.1396%
$6.35$50,394-13.1%
2014-03-27PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
1,700
0.0344%
$6.61$11,237-14.5%
2014-03-26PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
14,200
0.2876%
$6.66$94,619-15.08%
2014-03-25PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
303
0.0061%
$6.90$2,091-18.7%
2014-03-24PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
2,400
0.0465%
$6.71$16,104-19.29%
2014-03-21PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
4,900
0.1002%
$6.83$33,467-16.3%
2014-03-20PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
3,800
0.0768%
$6.90$26,220-18.1%
2014-03-17PurchaseAkari Therapeutics, Plc
AKTX
10 percent owner
2,400
0.0479%
$6.65$15,960-16.02%
Total: 18
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.